NCT06170723View on ClinicalTrials.gov

A Study to Assess the Effects of Itraconazole, Food, and pH on the Drug Levels of BMS-986368 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 18, 2024

Primary Completion Date

May 25, 2024

Study Completion Date

May 25, 2024

Conditions
Healthy Participants
Interventions
DRUG

BMS-986368

Specified dose on specified days

DRUG

Itraconazole

Specified dose on specified days

DRUG

Famotidine

Specified dose on specified days

Trial Locations (1)

85283

Local Institution - 0001, Tempe

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY